VFMFX
VANGUARD U.S. MULTIFACTOR FUND
VANGUARD WELLINGTON FUND
Expense ratio1
0.18%
Net assets2
$248.31M
Holdings2
601
Category
US Equity
2025 return3
15.06%

Investment objective & strategy

As of March 27, 2026 · prospectus

Objective. Vanguard U.S. Multifactor Fund (the Fund) seeks to provide long-term capital appreciation by investing in stocks with relatively strong recent performance, strong fundamentals, and low prices relative to fundamentals as determined by the advisor.

Strategy. The Fund employs an active management approach, investing primarily in U.S. common stocks with the potential to generate higher returns relative to the broad U.S. equity market by selecting stocks with relatively strong recent performance, strong fundamentals, and low prices relative to fundamentals as determined by the advisor. The Funds portfolio includes a diverse mix of companies representing many different market sectors and industry groups. The advisor uses a quantitative model to evaluate all of the securities in an investment universe comprised of U.S. large-, mid-, and small-capitalization stocks and to construct a U.S. equity portfolio that seeks to achieve exposure to multiple factors subject to a rules-based screen designed to promote diversification and to mitigate exposure to certain less … The Fund employs an active management approach, investing primarily in U.S. common stocks with the potential to generate higher returns relative to the broad U.S. equity market by selecting stocks with relatively strong recent performance, strong fundamentals, and low prices relative to fundamentals as determined by the advisor. The Funds portfolio includes a diverse mix of companies representing many different market sectors and industry groups. The advisor uses a quantitative model to evaluate all of the securities in an investment universe comprised of U.S. large-, mid-, and small-capitalization stocks and to construct a U.S. equity portfolio that seeks to achieve exposure to multiple factors subject to a rules-based screen designed to promote diversification and to mitigate exposure to certain less liquid and more volatile stocks. Under normal circumstances, the Fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in securities issued by U.S. companies.

Top holdings

As of Feb. 28, 2026 · N-PORT
SecurityTickerValue% of fund
NEWMONT CORP $2.70M 1.09%
MICRON TECHNOLOGY INC $2.34M 0.94%
GILEAD SCIENCES INC $2.26M 0.91%
HCA HEALTHCARE INC $2.25M 0.91%
BANK OF NEW YORK MELLON CORP $2.25M 0.90%
BRISTOL-MYERS SQUIBB CO $2.15M 0.87%
REGENERON PHARMACEUTICALS INC $2.11M 0.85%
ABBVIE INC $2.10M 0.85%
MCKESSON CORP $2.10M 0.84%
ALTRIA GROUP INC $2.04M 0.82%
View all holdings →

Allocation by sector

As of February 28, 2026 · N-PORT
View portfolio breakdown →

Portfolio moves

Nov 30, 2025 → Feb 28, 2026
Opened
154
Exited
103
Increased
152
Decreased
70
Unchanged
225

How many positions this fund opened, exited, grew, trimmed, or left unchanged between its two most recent N-PORT snapshots — net changes between point-in-time reports, not a trade log.

View portfolio moves →

Similar funds

Funds whose portfolios most overlap this one, by weight

Advisers

As of November 30, 2025 · N-CEN
FirmRole
The Vanguard Group, Inc. Adviser

Footnotes

  1. Expense ratio as of March 27, 2026, from the fund's prospectus.
  2. Net assets and holdings count as of February 28, 2026, from the fund's N-PORT filing.
  3. Total return for calendar year 2025, before tax and after fund expenses. As reported in the fund's prospectus performance bar chart.

Machine-readable: JSON · Markdown. Programmatic access via the agent surface.